Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06579521 · ClinicalTrials.gov registry record · NA

Real-world Experiences of Alcohol and Cognitions Over Time

A NA study of Alcohol Intoxication, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
92
Enrollment target
1
Study location

NCT06579521: Completed NA study of Alcohol Intoxication, sponsored by University of Washington.

NCT06579521 is a NA study of Alcohol Intoxication that has completed, run by University of Washington. The registered enrollment target is 92 participants, below the 342-participant average among 15 other Alcohol Intoxication trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06579521, a NA study of Alcohol Intoxication, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
92 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to examine how alcohol affects young adults' attention in both laboratory and real-world settings through phone-based cognitive tasks. The main questions this trial is designed to answer are: * How well do the phone-based cognitive tasks capture alcohol's effects on attention? * Does the effect of alcohol on attention contribute to risk-taking? Participants will complete cognitive tasks to assess attention before and after consuming a standard amount of alcohol in the laboratory, and during surveys completed through a phone app for eight weekends.

Primary Outcome

On a phone, participants will count the number of times a crosshair flashes in the center of the screen. Each trial will include between 1 and 4 flashes. There will be 6 trials per block. After a training block, there will be two blocks administered while sober. After alcohol consumption, three blocks will be administered on the ascending limb of the BrAC curve. Number of accurate responses will be evaluated.

Conditions Studied

Interventions

  • OTHER Alcohol

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2024-08-18
Est. Completion 2025-08-31
Phase NA
University of Washington

1,048 total trials

What the finished NCT06579521 record still lists

NCT06579521 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 342-participant average among 15 other Alcohol Intoxication trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Alcohol Intoxication appearing as the primary indexed condition, and to 1 intervention - of which Alcohol is the first listed.

NCT06579521 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT06579521 about?

NCT06579521 is a clinical study titled "Real-world Experiences of Alcohol and Cognitions Over Time". The goal of this clinical trial is to examine how alcohol affects young adults' attention in both laboratory and real-world settings through phone-based cognitive tasks. The main questions this trial is designed to answer are: * How well do the phone-based cognitive tasks capture alcohol's effects ...

What is the current status of trial NCT06579521?

This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2024-08-18. Estimated completion is 2025-08-31.

What conditions does trial NCT06579521 study?

This clinical trial studies the following conditions: Alcohol Intoxication.

What interventions are being tested in trial NCT06579521?

The interventions under investigation include: Alcohol (OTHER).

Who is sponsoring clinical trial NCT06579521?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06579521 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Intoxication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06579521's enrollment target sits among peer trials

92 12th of 15 higher than 4 of 15 other Alcohol Intoxication trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Intoxication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03184545 · 92 participants · Phase 3

    Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome

  • NCT04172532 · 92 participants · Phase 1

    Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • NCT04508088 · 92 participants

    Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

  • NCT04840602 · 92 participants · Phase 2

    Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06579521, the US trial registry maintained by the National Library of Medicine. NCT06579521 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.